The pharmacological landscape for managing erectile dysfunction (ED) has expanded significantly, offering patients a variety of options to improve their quality of life. At the center of this field are PDE5 inhibitors, a class of medication designed to address the physiological components of vascular performance. Understanding how these treatments work and how dosages are determined is essential for any patient working with a healthcare provider.
Topics
